APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-helminthic Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-helminthic Drugs Industry Growth and Trends Forecast to 2032

Report ID 173964890127 December 2025118 pages

Choose your research edition.

Industry ResearchAnti-helminthic Drugs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-helminthic Drugs Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Anti-helminthic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-helminthic Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-helminthic Drugs Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Anti-helminthic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-helminthic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-helminthic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-helminthic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-helminthic Drugs include Anhui Shengying Pharmaceutical Co., Ltd., Beijing Taiyang Pharmaceutical Co., Ltd., Chengdu Hengda Pharmaceutical Co., Ltd., Diao Group Chengdu Pharmaceutical Co., Ltd., Fujian Dongrui Pharmaceutical Co., Ltd., Guilin Nanyao Pharmaceutical Co., Ltd., Hubei Ruihua Pharmaceutical Co., Ltd., China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. and Jiaozuo Furuitang Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-helminthic Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-helminthic Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-helminthic Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-helminthic Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-helminthic Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-helminthic Drugs Market by Company

Anhui Shengying Pharmaceutical Co., Ltd.

Beijing Taiyang Pharmaceutical Co., Ltd.

Chengdu Hengda Pharmaceutical Co., Ltd.

Diao Group Chengdu Pharmaceutical Co., Ltd.

Fujian Dongrui Pharmaceutical Co., Ltd.

Guilin Nanyao Pharmaceutical Co., Ltd.

Hubei Ruihua Pharmaceutical Co., Ltd.

China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.

Jiaozuo Furuitang Pharmaceutical Co., Ltd.

Nanjing Pharmaceutical Factory Co., Ltd.

Shaanxi Hanwang Pharmaceutical Co., Ltd.

Shanghai SPH Xinyi Pharmaceutical Co., Ltd.

Shanghai Tengrui Pharmaceutical Co., Ltd.

Shaoxing Minsheng Pharmaceutical Co., Ltd.

Sichuan Tiande Pharmaceutical Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Zhejiang Anbet Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd.

Anti-helminthic Drugs Segment by Type

Pyrantel Pamoate

Piperazine

Mimbendazole

Praziquantel

Albendazole

Anti-helminthic Drugs Segment by Application

For Veterinary Use

For Human Use

Anti-helminthic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-helminthic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-helminthic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-helminthic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-helminthic Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-helminthic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pyrantel Pamoate Table 2. Major Company of Piperazine Table 3. Major Company of Mimbendazole Table 4. Major Company of Praziquantel Table 5. Major Company of Albendazole Table 6. Global Anti-helminthic Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 8. Global Anti-helminthic Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Anti-helminthic Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Anti-helminthic Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Anti-helminthic Drugs Price by Type (2021-2026) & (US$/Unit) Table 12. Global Anti-helminthic Drugs Sales by Type (2027-2032) & (K Units) Table 13. Global Anti-helminthic Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Anti-helminthic Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Anti-helminthic Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Anti-helminthic Drugs Price by Type (2027-2032) & (US$/Unit) Table 17. North America Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 18. North America Anti-helminthic Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 20. Europe Anti-helminthic Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Anti-helminthic Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 24. Latin America Anti-helminthic Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Anti-helminthic Drugs Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Anti-helminthic Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Anti-helminthic Drugs Industry Trends Table 28. Anti-helminthic Drugs Industry Drivers Table 29. Anti-helminthic Drugs Industry Opportunities and Challenges Table 30. Anti-helminthic Drugs Industry Restraints Table 31. Global Anti-helminthic Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Anti-helminthic Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Anti-helminthic Drugs Sales by Company (2021-2026) & (K Units) Table 34. Global Anti-helminthic Drugs Sales Share by Company (2021-2026) Table 35. Global Anti-helminthic Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Anti-helminthic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Anti-helminthic Drugs Major Company Production Sites and Headquarters Table 38. Global Anti-helminthic Drugs Company, Product Type & Application Table 39. Global Anti-helminthic Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Anti-helminthic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Anti-helminthic Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Anti-helminthic Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Anti-helminthic Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Anti-helminthic Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Anti-helminthic Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Anti-helminthic Drugs Sales by Region (2027-2032) & (K Units) Table 49. Global Anti-helminthic Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Anti-helminthic Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Anti-helminthic Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Anti-helminthic Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Anti-helminthic Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 55. Global Anti-helminthic Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Anti-helminthic Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Anti-helminthic Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Anti-helminthic Drugs Price by Application (2021-2026) & (US$/Unit) Table 59. Global Anti-helminthic Drugs Sales by Application (2027-2032) & (K Units) Table 60. Global Anti-helminthic Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Anti-helminthic Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Anti-helminthic Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Anti-helminthic Drugs Price by Application (2027-2032) & (US$/Unit) Table 64. North America Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 65. North America Anti-helminthic Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 67. Europe Anti-helminthic Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Anti-helminthic Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 71. Latin America Anti-helminthic Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Anti-helminthic Drugs Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Anti-helminthic Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Anhui Shengying Pharmaceutical Co., Ltd. Company Information Table 75. Anhui Shengying Pharmaceutical Co., Ltd. Business Overview Table 76. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 78. Anhui Shengying Pharmaceutical Co., Ltd. Recent Development Table 79. Beijing Taiyang Pharmaceutical Co., Ltd. Company Information Table 80. Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview Table 81. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 83. Beijing Taiyang Pharmaceutical Co., Ltd. Recent Development Table 84. Chengdu Hengda Pharmaceutical Co., Ltd. Company Information Table 85. Chengdu Hengda Pharmaceutical Co., Ltd. Business Overview Table 86. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 88. Chengdu Hengda Pharmaceutical Co., Ltd. Recent Development Table 89. Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information Table 90. Diao Group Chengdu Pharmaceutical Co., Ltd. Business Overview Table 91. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 93. Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Development Table 94. Fujian Dongrui Pharmaceutical Co., Ltd. Company Information Table 95. Fujian Dongrui Pharmaceutical Co., Ltd. Business Overview Table 96. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 98. Fujian Dongrui Pharmaceutical Co., Ltd. Recent Development Table 99. Guilin Nanyao Pharmaceutical Co., Ltd. Company Information Table 100. Guilin Nanyao Pharmaceutical Co., Ltd. Business Overview Table 101. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 103. Guilin Nanyao Pharmaceutical Co., Ltd. Recent Development Table 104. Hubei Ruihua Pharmaceutical Co., Ltd. Company Information Table 105. Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview Table 106. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 108. Hubei Ruihua Pharmaceutical Co., Ltd. Recent Development Table 109. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information Table 110. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview Table 111. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 113. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Development Table 114. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information Table 115. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Business Overview Table 116. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 118. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Development Table 119. Nanjing Pharmaceutical Factory Co., Ltd. Company Information Table 120. Nanjing Pharmaceutical Factory Co., Ltd. Business Overview Table 121. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 123. Nanjing Pharmaceutical Factory Co., Ltd. Recent Development Table 124. Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information Table 125. Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview Table 126. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 128. Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Development Table 129. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information Table 130. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview Table 131. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 133. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Development Table 134. Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information Table 135. Shanghai Tengrui Pharmaceutical Co., Ltd. Business Overview Table 136. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 138. Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Development Table 139. Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information Table 140. Shaoxing Minsheng Pharmaceutical Co., Ltd. Business Overview Table 141. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 143. Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Development Table 144. Sichuan Tiande Pharmaceutical Co., Ltd. Company Information Table 145. Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview Table 146. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 148. Sichuan Tiande Pharmaceutical Co., Ltd. Recent Development Table 149. Southwest Pharmaceutical Co., Ltd. Company Information Table 150. Southwest Pharmaceutical Co., Ltd. Business Overview Table 151. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 153. Southwest Pharmaceutical Co., Ltd. Recent Development Table 154. Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information Table 155. Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview Table 156. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 158. Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Development Table 159. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information Table 160. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview Table 161. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio Table 163. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development Table 164. North America Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. North America Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 166. North America Anti-helminthic Drugs Sales Market Share by Country (2021-2026) Table 167. North America Anti-helminthic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 168. North America Anti-helminthic Drugs Sales Market Share Forecast by Country (2027-2032) Table 169. North America Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. North America Anti-helminthic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 171. North America Anti-helminthic Drugs Market Share by Country (2021-2026) Table 172. North America Anti-helminthic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. North America Anti-helminthic Drugs Market Share Forecast by Country (2027-2032) Table 174. Europe Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 175. Europe Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 176. Europe Anti-helminthic Drugs Sales Market Share by Country (2021-2026) Table 177. Europe Anti-helminthic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 178. Europe Anti-helminthic Drugs Sales Market Share Forecast by Country (2027-2032) Table 179. Europe Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Europe Anti-helminthic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 181. Europe Anti-helminthic Drugs Market Share by Country (2021-2026) Table 182. Europe Anti-helminthic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Europe Anti-helminthic Drugs Market Share Forecast by Country (2027-2032) Table 184. Asia-Pacific Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 185. Asia-Pacific Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 186. Asia-Pacific Anti-helminthic Drugs Sales Market Share by Country (2021-2026) Table 187. Asia-Pacific Anti-helminthic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 188. Asia-Pacific Anti-helminthic Drugs Sales Market Share Forecast by Country (2027-2032) Table 189. Asia-Pacific Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Asia-Pacific Anti-helminthic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 191. Asia-Pacific Anti-helminthic Drugs Market Share by Country (2021-2026) Table 192. Asia-Pacific Anti-helminthic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Asia-Pacific Anti-helminthic Drugs Market Share Forecast by Country (2027-2032) Table 194. Latin America Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 195. Latin America Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 196. Latin America Anti-helminthic Drugs Sales Market Share by Country (2021-2026) Table 197. Latin America Anti-helminthic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 198. Latin America Anti-helminthic Drugs Sales Market Share Forecast by Country (2027-2032) Table 199. Latin America Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Latin America Anti-helminthic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 201. Latin America Anti-helminthic Drugs Market Share by Country (2021-2026) Table 202. Latin America Anti-helminthic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Latin America Anti-helminthic Drugs Market Share Forecast by Country (2027-2032) Table 204. Middle East and Africa Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 205. Middle East and Africa Anti-helminthic Drugs Sales by Country (2021-2026) & (K Units) Table 206. Middle East and Africa Anti-helminthic Drugs Sales Market Share by Country (2021-2026) Table 207. Middle East and Africa Anti-helminthic Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 208. Middle East and Africa Anti-helminthic Drugs Sales Market Share Forecast by Country (2027-2032) Table 209. Middle East and Africa Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 210. Middle East and Africa Anti-helminthic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 211. Middle East and Africa Anti-helminthic Drugs Market Share by Country (2021-2026) Table 212. Middle East and Africa Anti-helminthic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 213. Middle East and Africa Anti-helminthic Drugs Market Share Forecast by Country (2027-2032) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Anti-helminthic Drugs Distributors List Table 217. Anti-helminthic Drugs Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Anti-helminthic Drugs Image Figure 2. Global Anti-helminthic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-helminthic Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-helminthic Drugs Sales (2021-2032) & (K Units) Figure 5. Pyrantel Pamoate Image Figure 6. Global Pyrantel Pamoate Sales YoY Growth (2021-2032) & (K Units) Figure 7. Piperazine Image Figure 8. Global Piperazine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Mimbendazole Image Figure 10. Global Mimbendazole Sales YoY Growth (2021-2032) & (K Units) Figure 11. Praziquantel Image Figure 12. Global Praziquantel Sales YoY Growth (2021-2032) & (K Units) Figure 13. Albendazole Image Figure 14. Global Albendazole Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Anti-helminthic Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Anti-helminthic Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Anti-helminthic Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Anti-helminthic Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Anti-helminthic Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Anti-helminthic Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Anti-helminthic Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Anti-helminthic Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Anti-helminthic Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Anti-helminthic Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Anti-helminthic Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Anti-helminthic Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Anti-helminthic Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. For Veterinary Use Image Figure 30. Global For Veterinary Use Sales YoY Growth (2021-2032) & (K Units) Figure 31. For Human Use Image Figure 32. Global For Human Use Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Anti-helminthic Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Anti-helminthic Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Anti-helminthic Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Anti-helminthic Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Anti-helminthic Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Anti-helminthic Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Anti-helminthic Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Anti-helminthic Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Anti-helminthic Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Anti-helminthic Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Anti-helminthic Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Anti-helminthic Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Anti-helminthic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Anti-helminthic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Anti-helminthic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Anti-helminthic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Anti-helminthic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Anti-helminthic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anti-helminthic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Anti-helminthic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Anti-helminthic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Anti-helminthic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anti-helminthic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Anti-helminthic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anti-helminthic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Anti-helminthic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anti-helminthic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Anti-helminthic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Anti-helminthic Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Anti-helminthic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anti-helminthic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Anti-helminthic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Anti-helminthic Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Anti-helminthic Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Pyrantel Pamoate
  • Piperazine
  • Mimbendazole
  • Praziquantel
  • Albendazole
Applications
  • For Veterinary Use
  • For Human Use
Companies covered
  • Anhui Shengying Pharmaceutical Co., Ltd.
  • Beijing Taiyang Pharmaceutical Co., Ltd.
  • Chengdu Hengda Pharmaceutical Co., Ltd.
  • Diao Group Chengdu Pharmaceutical Co., Ltd.
  • Fujian Dongrui Pharmaceutical Co., Ltd.
  • Guilin Nanyao Pharmaceutical Co., Ltd.
  • Hubei Ruihua Pharmaceutical Co., Ltd.
  • China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  • Jiaozuo Furuitang Pharmaceutical Co., Ltd.
  • Nanjing Pharmaceutical Factory Co., Ltd.
  • Shaanxi Hanwang Pharmaceutical Co., Ltd.
  • Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  • Shanghai Tengrui Pharmaceutical Co., Ltd.
  • Shaoxing Minsheng Pharmaceutical Co., Ltd.
  • Sichuan Tiande Pharmaceutical Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Zhejiang Anbet Pharmaceutical Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-helminthic Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-helminthic Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-helminthic Drugs Market by Type
  6. 1.3.1 Pyrantel Pamoate
  7. 1.3.2 Piperazine
  8. 1.3.3 Mimbendazole
  9. 1.3.4 Praziquantel
  10. 1.3.5 Albendazole
  11. 1.4 Global Anti-helminthic Drugs Market Size by Type
  12. 1.4.1 Global Anti-helminthic Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Anti-helminthic Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Anti-helminthic Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Anti-helminthic Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Anti-helminthic Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Anti-helminthic Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Anti-helminthic Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Anti-helminthic Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-helminthic Drugs Industry Trends
  2. 2.2 Anti-helminthic Drugs Industry Drivers
  3. 2.3 Anti-helminthic Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-helminthic Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-helminthic Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-helminthic Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-helminthic Drugs Price (2021-2026)
  4. 3.4 Global Anti-helminthic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-helminthic Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-helminthic Drugs Company, Product Type & Application
  7. 3.7 Global Anti-helminthic Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-helminthic Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-helminthic Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-helminthic Drugs Tier 1, Tier 2, and Tier 3
4 Anti-helminthic Drugs Regional Status and Outlook
  1. 4.1 Global Anti-helminthic Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-helminthic Drugs Historic Market Size by Region
  3. 4.2.1 Global Anti-helminthic Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-helminthic Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-helminthic Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-helminthic Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Anti-helminthic Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-helminthic Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-helminthic Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-helminthic Drugs by Application
  1. 5.1 Anti-helminthic Drugs Market by Application
  2. 5.1.1 For Veterinary Use
  3. 5.1.2 For Human Use
  4. 5.2 Global Anti-helminthic Drugs Market Size by Application
  5. 5.2.1 Global Anti-helminthic Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Anti-helminthic Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Anti-helminthic Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Anti-helminthic Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Anti-helminthic Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Anti-helminthic Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Anti-helminthic Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Anti-helminthic Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Anhui Shengying Pharmaceutical Co., Ltd.
  2. 6.1.1 Anhui Shengying Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Anhui Shengying Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  6. 6.1.5 Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Beijing Taiyang Pharmaceutical Co., Ltd.
  8. 6.2.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  12. 6.2.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Chengdu Hengda Pharmaceutical Co., Ltd.
  14. 6.3.1 Chengdu Hengda Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Chengdu Hengda Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  18. 6.3.5 Chengdu Hengda Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Diao Group Chengdu Pharmaceutical Co., Ltd.
  20. 6.4.1 Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Diao Group Chengdu Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  24. 6.4.5 Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Fujian Dongrui Pharmaceutical Co., Ltd.
  26. 6.5.1 Fujian Dongrui Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Fujian Dongrui Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  30. 6.5.5 Fujian Dongrui Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Guilin Nanyao Pharmaceutical Co., Ltd.
  32. 6.6.1 Guilin Nanyao Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Guilin Nanyao Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  36. 6.6.5 Guilin Nanyao Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Hubei Ruihua Pharmaceutical Co., Ltd.
  38. 6.7.1 Hubei Ruihua Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Hubei Ruihua Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  42. 6.7.5 Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  44. 6.8.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  48. 6.8.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Jiaozuo Furuitang Pharmaceutical Co., Ltd.
  50. 6.9.1 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  54. 6.9.5 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Nanjing Pharmaceutical Factory Co., Ltd.
  56. 6.10.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
  57. 6.10.2 Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
  58. 6.10.3 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolio
  60. 6.10.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments
  61. 6.11 Shaanxi Hanwang Pharmaceutical Co., Ltd.
  62. 6.11.1 Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  66. 6.11.5 Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  68. 6.12.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  72. 6.12.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Shanghai Tengrui Pharmaceutical Co., Ltd.
  74. 6.13.1 Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Shanghai Tengrui Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  78. 6.13.5 Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Shaoxing Minsheng Pharmaceutical Co., Ltd.
  80. 6.14.1 Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Shaoxing Minsheng Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  84. 6.14.5 Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Sichuan Tiande Pharmaceutical Co., Ltd.
  86. 6.15.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  90. 6.15.5 Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Southwest Pharmaceutical Co., Ltd.
  92. 6.16.1 Southwest Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  96. 6.16.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Zhejiang Anbet Pharmaceutical Co., Ltd.
  98. 6.17.1 Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Zhejiang Anbet Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  102. 6.17.5 Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Zhejiang Hisun Pharmaceutical Co., Ltd.
  104. 6.18.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
  105. 6.18.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
  106. 6.18.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio
  108. 6.18.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Anti-helminthic Drugs Sales by Country
  2. 7.1.1 North America Anti-helminthic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-helminthic Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-helminthic Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-helminthic Drugs Market Size by Country
  6. 7.2.1 North America Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-helminthic Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-helminthic Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-helminthic Drugs Sales by Country
  2. 8.1.1 Europe Anti-helminthic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-helminthic Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-helminthic Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-helminthic Drugs Market Size by Country
  6. 8.2.1 Europe Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-helminthic Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-helminthic Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-helminthic Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Anti-helminthic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-helminthic Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-helminthic Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-helminthic Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-helminthic Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-helminthic Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-helminthic Drugs Sales by Country
  2. 10.1.1 South America Anti-helminthic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-helminthic Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-helminthic Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-helminthic Drugs Market Size by Country
  6. 10.2.1 South America Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-helminthic Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-helminthic Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-helminthic Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Anti-helminthic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-helminthic Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-helminthic Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-helminthic Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-helminthic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-helminthic Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-helminthic Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-helminthic Drugs Value Chain Analysis
  2. 12.1.1 Anti-helminthic Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-helminthic Drugs Production Mode & Process
  7. 12.2 Anti-helminthic Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-helminthic Drugs Distributors
  10. 12.2.3 Anti-helminthic Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst